✦ LIBER ✦

Neutrophil gelatinase-associated lipocalin as a biomarker of disease activity in pediatric lupus nephritis

✍ Scribed by Michiko Suzuki; Kristina M. Wiers; Marisa S. Klein-Gitelman; Kathleen A. Haines; Judyann Olson; Karen B. Onel; Kathleen O’Neil; Murray H. Passo; Nora G. Singer; Lori Tucker; Jun Ying; Prasad Devarajan; Hermine I. Brunner

Publisher: Springer
Year: 2008
Tongue: English
Weight: 240 KB
Volume: 23
Category: Article
ISSN: 0931-041X
DOI: 10.1007/s00467-007-0685-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Urinary neutrophil gelatinase–associated

Urinary neutrophil gelatinase–associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus

✍ Hermine I. Brunner; Michelle Mueller; Cynthia Rutherford; Murray H. Passo; David 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB 👁 2 views

Neutrophil gelatinase–associated lipocal

Neutrophil gelatinase–associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity

✍ Claas H. Hinze; Michiko Suzuki; Marisa Klein-Gitelman; Murray H. Passo; Judyann 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 3 views

Serum neutrophil gelatinase-associated l

Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in children with chronic kidney disease

✍ Mark M. Mitsnefes; Thelma S. Kathman; Jaya Mishra; Janis Kartal; Philip R. Khour 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 216 KB

Expressions of Neutrophil Gelatinase-Ass

Expressions of Neutrophil Gelatinase-Associated Lipocalin in Gastric Cancer: A Potential Biomarker for Prognosis and an Ancillary Diagnostic Test

✍ Hui-Ju Wang; Xu-Jun He; Ying-Yu Ma; Xiao-Ting Jiang; Ying-Jie Xia; Zai-Yuan Ye; 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 579 KB

## Abstract The aim of this study was to explore the clinical significance of neutrophil gelatinase‐associated lipocalin (NGAL) in the development and prognosis of gastric cancer. NGAL tumor levels were determined in 333 GC patients by immunohistochemistry. NGAL in blood samples from 63 healthy don